ABSTRACT Introduction Metabolic syndrome (MetS), ie the cluster of cardiometabolic risk
factors comprising visceral obesity, impaired glucose metabolism, arterial hypertension and …

For adopting recently introduced hypertension phenotypes categorized using office and out
of office blood pressure (BP) for the diagnosis of hypertension and antihypertension drug …

Introduction: Data on the association between blood pressure variability (BPV) after
endovascular thrombectomy (EVT) for acute ischemic stroke (AIS) and outcomes are limited …

Background Hypertension guidelines recommend diagnosis and treatment of obstructive
sleep apnea (OSA) in patients with hypertension. The mandibular advancement device …

The ambulatory arterial stiffness index (AASI) is a novel measure of both blood pressure
(BP) variability and arterial stiffness. This systematic review and meta‐analysis was …

This is a very common question clinicians encounter when discussing the option of starting a
pharmacological treatment for attention-deficit/hyperactivity disorder (ADHD), which includes …

Aims We investigated the associations between time in target range (TTR) of blood pressure
(BP) and cardiovascular outcomes in patients with diabetes. Methods 4651 participants from …

Perirenal adipose tissue (PRAT) surrounding the kidney is emerging as a player and novel
independent risk factor in diabetic kidney disease (DKD); DKD is a complication of diabetes …

Apparent-treatment resistant hypertension (aTRH) is defined as an elevated blood pressure
(BP), despite the use of≥ 3 antihypertensive medications from different classes or the use …

We describe herein the European Reference Network on Rare Endocrine Conditions clinical
practice guideline on diagnosis and management of familial forms of hyperaldosteronism …